Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-06-05 Third Rock Ventures III, L.P. 10% owner Conversion · Series A Preferred Stock −15,250,000 0
2020-06-05 Exter Neil Director Conversion +0 0
2020-06-05 Exter Neil Director Conversion · Series A Preferred Stock −0 0
2020-06-05 Coulie Bernard President and CEO Conversion +25,397 474,317
2020-06-05 Coulie Bernard President and CEO Conversion · Series B Preferred Stock −181,594 0
2020-04-30 Cummings Keith Lamont Chief Financial Officer Exercise or conversion +19,300 $2.08 $40K 19,300
2020-04-30 Cummings Keith Lamont Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −19,300 206,188
2020-04-30 Coulie Bernard President and CEO Exercise or conversion +613 $6.22 $4K 613
2020-04-30 Coulie Bernard President and CEO Exercise or conversion +48,227 $2.08 $100K 48,840
2020-04-30 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −613 376,723
2020-04-30 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −48,227 343,380
2020-03-31 Hull Hans Chief Business Officer Grant or award · Stock Option (right to buy) +70,352 70,352
2020-03-31 Cummings Keith Lamont Chief Financial Officer Grant or award · Stock Option (right to buy) +42,841 42,841
2020-03-31 Howes Barbara Chief Human Resource Officer Grant or award · Stock Option (right to buy) +7,584 7,584
2020-03-31 Exter Neil Director Grant or award · Stock Option (right to buy) +26,573 26,573
2020-03-31 Coulie Bernard President and CEO Grant or award · Stock Option (right to buy) +377,336 377,336
2020-02-28 Hull Hans Chief Business Officer Grant or award · Series C Preferred Stock +27,322 $13.08 $357K 27,322
2020-02-28 Cummings Keith Lamont Chief Financial Officer Grant or award · Series C Preferred Stock +27,322 $13.08 $357K 27,322
2020-02-27 Howes Barbara Chief Human Resource Officer Grant or award · Series C Preferred Stock +27,322 $13.08 $357K 27,322

Page 19 of 19 · 379 trades